Pharma companies are facing pricing pressure from several directions, including from the U.S. Medicare negotiations ...

CDMO-linked chemical makers are pulling ahead as tariff shocks, Chinese oversupply, and weak global demand hit the broader ...

India's pharmaceutical exports thrive at $30.46 billion, overcoming tariff concerns and showcasing strong growth in generics and biologics.

For the second year in a row, the pharmaceutical industry has dipped further out of favor with patient groups around the world. The industry’s reputation surged during the COVID-19 pandemic, according ...

ZURICH (Reuters) -Switzerland's economy contracted by 0.5% in the third quarter when adjusted for sporting events, driven by lower exports in the chemical and pharmaceutical industry, the economy ...

India's pharmaceutical industry must shift towards innovation in complex generics, including peptides, biosimilars, and ...

The Indian pharma industry is urged to innovate in complex generics like peptides, biosimilars, and biologics to maintain its ...

Drugmakers claim that broad state PFAS laws are overly burdensome. But environmental health experts aren’t convinced.

How pharma–hospital partnerships can overcome operational, financial, and organizational barriers to build high-performing clinical trial programs that expand access, accelerate accrual, and ...

According to details surfaced on Thursday, the Competition Commission of Pakistan (CCP) and the Drug Regulatory Authority ...

The Uttar Pradesh food and drugs department has filed cases against 12 more pharmaceutical firms implicated in a codeine ...